• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆患者血浆24S-羟基胆固醇和27-羟基胆固醇水平的改变

Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.

作者信息

Kölsch H, Heun R, Kerksiek A, Bergmann K V, Maier W, Lütjohann D

机构信息

Department of Psychiatry, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.

出版信息

Neurosci Lett. 2004 Sep 30;368(3):303-8. doi: 10.1016/j.neulet.2004.07.031.

DOI:10.1016/j.neulet.2004.07.031
PMID:15364416
Abstract

Alterations in brain cholesterol metabolism and reduced 24S-hydroxycholesterol plasma levels have been described in Alzheimer's disease (AD) and vascular dementia (VD). We hypothesize that changes in peripheral cholesterol metabolism, such as alterations in the plasma levels of 27-hydroxycholesterol, might also be involved. Plasma levels of 24S-hydroxycholesterol and 27-hydroxycholesterol in patients suffering from dementing disorders such as AD, VD, and mild cognitive impairment (MCI) were compared to those in age- and cholesterol matched non-demented and depressed subjects. Cholesterol corrected concentrations of plasma 24S-hydroxycholesterol and 27-hydroxycholesterol were significantly reduced in patients with dementing disorders compared to non-demented subjects and depressed patients. A strong positive correlation between plasma 24S-hydroxycholesterol and 27-hydroxycholesterol levels was observed. The ratios of plasma 24S-hydroxycholesterol to 27-hydroxycholesterol were higher in patients with dementing disorders compared to non-demented subjects. Our results support the observation, that cholesterol metabolism is altered in dementing disorders, indicated by different plasma concentrations of brain specific and peripherally produced oxysterols.

摘要

阿尔茨海默病(AD)和血管性痴呆(VD)患者存在脑胆固醇代谢改变以及血浆24S-羟基胆固醇水平降低的情况。我们推测外周胆固醇代谢的变化,如27-羟基胆固醇血浆水平的改变,可能也与之相关。将患有痴呆症(如AD、VD和轻度认知障碍(MCI))的患者的血浆24S-羟基胆固醇和27-羟基胆固醇水平与年龄和胆固醇水平匹配的非痴呆及抑郁受试者进行比较。与非痴呆受试者和抑郁患者相比,患有痴呆症的患者经胆固醇校正后的血浆24S-羟基胆固醇和27-羟基胆固醇浓度显著降低。观察到血浆24S-羟基胆固醇和27-羟基胆固醇水平之间存在强正相关。与非痴呆受试者相比,患有痴呆症的患者血浆24S-羟基胆固醇与27-羟基胆固醇的比值更高。我们的结果支持以下观察结果:痴呆症患者的胆固醇代谢发生改变,这由脑特异性和外周产生的氧化甾醇的不同血浆浓度所表明。

相似文献

1
Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.痴呆患者血浆24S-羟基胆固醇和27-羟基胆固醇水平的改变
Neurosci Lett. 2004 Sep 30;368(3):303-8. doi: 10.1016/j.neulet.2004.07.031.
2
24S-hydroxycholesterol: a marker of brain cholesterol metabolism.24S-羟基胆固醇:脑胆固醇代谢的标志物。
Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6. doi: 10.1055/s-2003-43053.
3
Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.阿尔茨海默病患者和血管性痴呆患者的血浆24S-羟基胆固醇(脑甾醇)水平升高。
J Lipid Res. 2000 Feb;41(2):195-8.
4
24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.脑脊液中的24S-羟基胆固醇在痴呆症早期会升高。
J Psychiatr Res. 2002 Jan-Feb;36(1):27-32. doi: 10.1016/s0022-3956(01)00050-4.
5
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.他汀类药物治疗对阿尔茨海默病患者24S-羟基胆固醇水平的降低作用。
Arch Neurol. 2003 Apr;60(4):510-5. doi: 10.1001/archneur.60.4.510.
6
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.24S-羟基胆固醇的血浆水平反映了无客观认知障碍患者的脑容量,但在阿尔茨海默病患者中并非如此。
Neurosci Lett. 2009 Oct 2;462(1):89-93. doi: 10.1016/j.neulet.2009.06.073. Epub 2009 Jun 26.
7
Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.老年晚发性阿尔茨海默病或血管性痴呆患者血浆 24S-羟基胆固醇水平:病例对照研究。
BMC Neurol. 2011 Oct 4;11:121. doi: 10.1186/1471-2377-11-121.
8
Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.血浆24S-羟基胆固醇:神经元变性的外周指标及阿尔茨海默病的潜在状态标志物。
Neuroreport. 2000 Jun 26;11(9):1959-62. doi: 10.1097/00001756-200006260-00030.
9
The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.性别、CYP46和载脂蛋白E基因多态性对他汀类药物治疗的阿尔茨海默病患者24S-羟基胆固醇水平的影响。
Curr Alzheimer Res. 2004 Feb;1(1):71-7. doi: 10.2174/1567205043480546.
10
Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?血浆中脑特异性24S-羟基胆固醇是否表明缺血性中风患者血脑屏障遭到破坏?
Neurosci Lett. 2004 Sep 23;368(2):201-4. doi: 10.1016/j.neulet.2004.07.012.

引用本文的文献

1
Association Between Rest-Activity Rhythm and 27-Hydroxycholesterol (27-OH) in Patients with Amnestic Mild Cognitive Impairment (aMCI).遗忘型轻度认知障碍(aMCI)患者的静息-活动节律与27-羟基胆固醇(27-OH)之间的关联。
J Clin Med. 2025 Aug 4;14(15):5481. doi: 10.3390/jcm14155481.
2
The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease.血浆 24S-羟基胆固醇和其他氧化固醇定量在神经退行性疾病中的诊断应用。
Adv Exp Med Biol. 2024;1440:337-351. doi: 10.1007/978-3-031-43883-7_17.
3
Enzymatically Formed Oxysterols and Cell Death.
酶促形成的氧化固醇与细胞死亡。
Adv Exp Med Biol. 2024;1440:193-211. doi: 10.1007/978-3-031-43883-7_10.
4
Altered Cholesterol Homeostasis in Huntington's Disease.亨廷顿舞蹈病中胆固醇稳态的改变
Front Aging Neurosci. 2022 Apr 19;14:797220. doi: 10.3389/fnagi.2022.797220. eCollection 2022.
5
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.胆固醇羟化细胞色素P450 46A1:从作用机制到临床应用
Front Aging Neurosci. 2021 Jul 8;13:696778. doi: 10.3389/fnagi.2021.696778. eCollection 2021.
6
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease.24-S-羟基胆固醇在阿尔茨海默病中的争议性作用
Antioxidants (Basel). 2021 May 7;10(5):740. doi: 10.3390/antiox10050740.
7
Blood Lipids and Cognitive Performance of Aging Polish Adults: A Case-Control Study Based on the PolSenior Project.波兰老年成年人的血脂与认知表现:基于PolSenior项目的病例对照研究
Front Aging Neurosci. 2020 Nov 17;12:590546. doi: 10.3389/fnagi.2020.590546. eCollection 2020.
8
Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis.Sigma-2 受体——通过调节胆固醇稳态治疗癌症/阿尔茨海默病的潜在靶点。
Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.
9
Nutritional Lipidomics in Alzheimer's Disease.阿尔茨海默病的营养脂质组学。
Adv Exp Med Biol. 2020;1195:95-104. doi: 10.1007/978-3-030-32633-3_14.
10
Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer's disease.氧化胆固醇作为大脑中的信号分子:糖尿病与阿尔茨海默病
Neuronal Signal. 2019 Dec;3(4):NS20190068. doi: 10.1042/NS20190068. Epub 2019 Nov 28.